{
  "functional_evidence_assessment": [
    {
      "variant_id": {
        "Gene": "LRRK2",
        "Protein_Change": {
          "ref": "G",
          "alt": "S",
          "position": "2019"
        },
        "variant_string_id": "LRRK2 G2019S"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "Mutations in the leucine-rich repeat kinase 2 (LRRK2) gene are currently recognized as the most common genetic cause of parkinsonism. Among the large number of LRRK2 mutations identified to date, the G2019S variant is the most common.",
          "judgment": "Yes",
          "reasoning": "The paper clearly defines the disease mechanism as related to LRRK2 mutations being a common genetic cause of parkinsonism, specifically mentioning the G2019S variant."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "We found that transgenic flies harboring G2019S...LRRK2 variant, but not the wild-type protein, exhibit late-onset loss of dopaminergic (DA) neurons in selected clusters that is accompanied by locomotion deficits. Furthermore, LRRK2 mutant flies also display reduced lifespan and increased sensitivity to rotenone, a mitochondrial complex I inhibitor.",
          "judgment": "Yes",
          "reasoning": "The assay used, observing DA neuron loss, locomotion deficits, and sensitivity to rotenone in a Drosophila model, effectively models the disease pathogenesis of Parkinson's, which is characterized by DA neuron loss and motor dysfunction. Increased rotenone sensitivity also supports this.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Sub-step 3a: Basic Controls and Replicates",
          "extracted_paper_info": "We found that transgenic flies harboring G2019S...LRRK2 variant, but not the wild-type protein, exhibit late-onset loss of dopaminergic (DA) neurons...Locomotion deficits...reduced lifespan...increased sensitivity to rotenone...",
          "judgment": "Yes",
          "reasoning": "The study includes a 'wild-type protein' control group and implicitly an abnormal/positive group (flies with G2019S mutation). Multiple replicates were used, as indicated by the statement 'Three groups of 20 female adult flies...' for climbing assays and the use of multiple flies for other assays such as TH+ neuron counts. In addition, results are presented as mean +/- SEM implying multiple experiments.",
          "next_step_or_outcome": "Proceed to Sub-step 3c"
        },
        {
          "step_name": "Sub-step 3c: Variant Controls",
          "extracted_paper_info": "N/A",
          "judgment": "No",
          "reasoning": "The paper does not mention the use of any known pathogenic or benign variants as controls, or variants tested that reach P/LP or B/LB criteria without relying on PS3/BS3 evidence themselves.",
          "next_step_or_outcome": "The functional evidence strength is Max PS3_supporting / Max BS3_supporting."
        },
        {
          "step_name": "Sub-step 4a: Statistical Analyses",
          "extracted_paper_info": "Quantitative data are expressed as mean ± SEM, unless otherwise stated. Statistical significance for all the quantitative data obtained was analyzed using the Student's t test (*p < 0.05, **p < 0.001), unless otherwise stated.",
          "judgment": "No",
          "reasoning": "The statistical analysis (Student's t-test and p-values) is insufficient to calculate a direct OddsPath value.",
          "next_step_or_outcome": "Proceed to Sub-step 4b"
        },
        {
          "step_name": "Sub-step 4b: No OddsPath Calculation",
          "extracted_paper_info": "N/A",
          "judgment": "Yes",
          "reasoning": "The paper uses a wild-type LRRK2 control. However, there are no additional benign controls or additional pathogenic controls mentioned. So the number of pathogenic and benign variant controls used in the assay is less than 10 in total.",
          "next_step_or_outcome": "The functional evidence strength is Max PS3_supporting"
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_supporting"
      },
      "overall_conclusion": "The LRRK2 G2019S mutation exhibits a pathogenic effect through late-onset DA neuron loss, locomotion deficits, and increased sensitivity to rotenone in a Drosophila model, supported by statistical significance compared to the wild-type protein. With basic controls and replicates, but without variant controls or odds path calculation, it merits a PS3_supporting rating."
    },
    {
      "variant_id": {
        "Gene": "LRRK2",
        "Protein_Change": {
          "ref": "Y",
          "alt": "C",
          "position": "1699"
        },
        "variant_string_id": "LRRK2 Y1699C"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "Mutations in the leucine-rich repeat kinase 2 (LRRK2) gene are currently recognized as the most common genetic cause of parkinsonism. To better understand the contribution of different LRRK2 variants toward disease pathogenesis, we generated transgenic Drosophila over-expressing various human LRRK2 alleles, including...Y1699C...",
          "judgment": "Yes",
          "reasoning": "The paper clearly defines the disease mechanism as related to LRRK2 mutations being a common genetic cause of parkinsonism, specifically mentioning the Y1699C variant."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "We found that transgenic flies harboring...Y1699C...LRRK2 variant, but not the wild-type protein, exhibit late-onset loss of dopaminergic (DA) neurons in selected clusters that is accompanied by locomotion deficits. Furthermore, LRRK2 mutant flies also display reduced lifespan...",
          "judgment": "Yes",
          "reasoning": "The assay used, observing DA neuron loss and locomotion deficits in a Drosophila model, effectively models the disease pathogenesis of Parkinson's, which is characterized by DA neuron loss and motor dysfunction.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Sub-step 3a: Basic Controls and Replicates",
          "extracted_paper_info": "We found that transgenic flies harboring...Y1699C...LRRK2 variant, but not the wild-type protein, exhibit late-onset loss of dopaminergic (DA) neurons...Locomotion deficits...reduced lifespan...",
          "judgment": "Yes",
          "reasoning": "The study includes a 'wild-type protein' control group and an abnormal/positive group (flies with Y1699C mutation). Multiple replicates were used, as indicated by the statement 'Three groups of 20 female adult flies...' for climbing assays and the use of multiple flies for other assays such as TH+ neuron counts. In addition, results are presented as mean +/- SEM implying multiple experiments.",
          "next_step_or_outcome": "Proceed to Sub-step 3c"
        },
        {
          "step_name": "Sub-step 3c: Variant Controls",
          "extracted_paper_info": "N/A",
          "judgment": "No",
          "reasoning": "The paper does not mention the use of any known pathogenic or benign variants as controls, or variants tested that reach P/LP or B/LB criteria without relying on PS3/BS3 evidence themselves.",
          "next_step_or_outcome": "The functional evidence strength is Max PS3_supporting / Max BS3_supporting."
        },
        {
          "step_name": "Sub-step 4a: Statistical Analyses",
          "extracted_paper_info": "Quantitative data are expressed as mean ± SEM, unless otherwise stated. Statistical significance for all the quantitative data obtained was analyzed using the Student's t test (*p < 0.05, **p < 0.001), unless otherwise stated.",
          "judgment": "No",
          "reasoning": "The statistical analysis (Student's t-test and p-values) is insufficient to calculate a direct OddsPath value.",
          "next_step_or_outcome": "Proceed to Sub-step 4b"
        },
        {
          "step_name": "Sub-step 4b: No OddsPath Calculation",
          "extracted_paper_info": "N/A",
          "judgment": "Yes",
          "reasoning": "The paper uses a wild-type LRRK2 control. However, there are no additional benign controls or additional pathogenic controls mentioned. So the number of pathogenic and benign variant controls used in the assay is less than 10 in total.",
          "next_step_or_outcome": "The functional evidence strength is Max PS3_supporting"
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_supporting"
      },
      "overall_conclusion": "The LRRK2 Y1699C mutation exhibits a pathogenic effect through late-onset DA neuron loss and locomotion deficits in a Drosophila model, supported by statistical significance compared to the wild-type protein. With basic controls and replicates, but without variant controls or odds path calculation, it merits a PS3_supporting rating."
    },
    {
      "variant_id": {
        "Gene": "LRRK2",
        "Protein_Change": {
          "ref": "G",
          "alt": "R",
          "position": "2385"
        },
        "variant_string_id": "LRRK2 G2385R"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "Mutations in the leucine-rich repeat kinase 2 (LRRK2) gene are currently recognized as the most common genetic cause of parkinsonism. In Asia, however, another LRRK2 variant, G2385R, appears to occur more frequently. To better understand the contribution of different LRRK2 variants toward disease pathogenesis, we generated transgenic Drosophila over-expressing various human LRRK2 alleles, including...G2385R LRRK2.",
          "judgment": "Yes",
          "reasoning": "The paper clearly defines the disease mechanism as related to LRRK2 mutations being a common genetic cause of parkinsonism, specifically mentioning the G2385R variant."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "We found that transgenic flies harboring...G2385R LRRK2 variant, but not the wild-type protein, exhibit late-onset loss of dopaminergic (DA) neurons in selected clusters that is accompanied by locomotion deficits. Furthermore, LRRK2 mutant flies also display reduced lifespan...",
          "judgment": "Yes",
          "reasoning": "The assay used, observing DA neuron loss and locomotion deficits in a Drosophila model, effectively models the disease pathogenesis of Parkinson's, which is characterized by DA neuron loss and motor dysfunction.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Sub-step 3a: Basic Controls and Replicates",
          "extracted_paper_info": "We found that transgenic flies harboring...G2385R LRRK2 variant, but not the wild-type protein, exhibit late-onset loss of dopaminergic (DA) neurons...locomotion deficits...reduced lifespan...",
          "judgment": "Yes",
          "reasoning": "The study includes a 'wild-type protein' control group and an abnormal/positive group (flies with G2385R mutation). Multiple replicates were used, as indicated by the statement 'Three groups of 20 female adult flies...' for climbing assays and the use of multiple flies for other assays such as TH+ neuron counts. In addition, results are presented as mean +/- SEM implying multiple experiments.",
          "next_step_or_outcome": "Proceed to Sub-step 3c"
        },
        {
          "step_name": "Sub-step 3c: Variant Controls",
          "extracted_paper_info": "N/A",
          "judgment": "No",
          "reasoning": "The paper does not mention the use of any known pathogenic or benign variants as controls, or variants tested that reach P/LP or B/LB criteria without relying on PS3/BS3 evidence themselves.",
          "next_step_or_outcome": "The functional evidence strength is Max PS3_supporting / Max BS3_supporting."
        },
        {
          "step_name": "Sub-step 4a: Statistical Analyses",
          "extracted_paper_info": "Quantitative data are expressed as mean ± SEM, unless otherwise stated. Statistical significance for all the quantitative data obtained was analyzed using the Student's t test (*p < 0.05, **p < 0.001), unless otherwise stated.",
          "judgment": "No",
          "reasoning": "The statistical analysis (Student's t-test and p-values) is insufficient to calculate a direct OddsPath value.",
          "next_step_or_outcome": "Proceed to Sub-step 4b"
        },
        {
          "step_name": "Sub-step 4b: No OddsPath Calculation",
          "extracted_paper_info": "N/A",
          "judgment": "Yes",
          "reasoning": "The paper uses a wild-type LRRK2 control. However, there are no additional benign controls or additional pathogenic controls mentioned. So the number of pathogenic and benign variant controls used in the assay is less than 10 in total.",
          "next_step_or_outcome": "The functional evidence strength is Max PS3_supporting"
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_supporting"
      },
      "overall_conclusion": "The LRRK2 G2385R mutation exhibits a pathogenic effect through late-onset DA neuron loss, and reduced lifespan in a Drosophila model, supported by statistical significance compared to the wild-type protein. With basic controls and replicates, but without variant controls or odds path calculation, it merits a PS3_supporting rating."
      }
    ]
}
